Search research articles
Contact Us
Filters
Showing results (41-50 of 115) with videos related to
Page
of 12
Sort By:
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
September 2, 2011
Association between the angiotensinogen gene T174M polymorphism and hypertension risk in the Chinese population: a meta-analysis
Wei Gu, Ya Liu, Zuoguang Wang, et al.
Chemosphere
|
November 8, 2024
Evaluating AGS efficiency in PHA synthesis and extraction integrated with nutrient removal: The impact of COD concentrations
Quan Yuan, Song Chen, Yun Chen, et al.
Oncotarget
|
September 17, 2016
Comparison of outcomes of tyrosine kinase inhibitor in first- or second-line therapy for advanced non-small-cell lung cancer patients with sensitive EGFR mutations
Jianlin Xu, Xueyan Zhang, Haitang Yang, et al.
Frontiers in Cell and Developmental Biology
|
April 1, 2022
Multi-Omics Signatures Identification for LUAD Prognosis Prediction Model Based on the Integrative Analysis of Immune and Hypoxia Signals
Yuqing Lou, Qin Shi, Yanwei Zhang, et al.
Cancer Cell International
|
January 7, 2021
PlGF knockdown attenuates hypoxia-induced stimulation of cell proliferation and glycolysis of lung adenocarcinoma through inhibiting Wnt/β-catenin pathway
Wei Zhang, Yanwei Zhang, Wensheng Zhou, et al.
Oncotargets and Therapy
|
November 2, 2016
The EGFR tyrosine kinase inhibitors as second-line therapy for EGFR wild-type non-small-cell lung cancer: a real-world study in People's Republic of China
Jianlin Xu, Guozheng Ding, Xueyan Zhang, et al.
Cancer Letters
|
February 17, 2022
The centromere-associated protein CENPU promotes cell proliferation, migration, and invasiveness in lung adenocarcinoma
Yuqing Lou, Jun Lu, Yanwei Zhang, et al.
Journal of Cellular and Molecular Medicine
|
February 20, 2020
Serum TNFRII: A promising biomarker for predicting the risk of subcentimetre lung adenocarcinoma
Minjuan Hu, Yanwei Zhang, Beibei Sun, et al.
Plos One
|
October 8, 2010
Alpha-adducin Gly460Trp polymorphism and hypertension risk: a meta-analysis of 22 studies including 14303 cases and 15961 controls
Kuo Liu, Jielin Liu, Yan Huang, et al.
Scientific Reports
|
December 2, 2016
Corrigendum: EGFR tyrosine kinase inhibitors versus chemotherapy as first-line therapy for non-small cell lung cancer patients with the L858R point mutation
Jianlin Xu, Haitang Yang, Bo Jin, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 115) with videos related to
Sort By:
Page
of 12
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
September 2, 2011
Association between the angiotensinogen gene T174M polymorphism and hypertension risk in the Chinese population: a meta-analysis
Wei Gu, Ya Liu, Zuoguang Wang, et al.
Chemosphere
|
November 8, 2024
Evaluating AGS efficiency in PHA synthesis and extraction integrated with nutrient removal: The impact of COD concentrations
Quan Yuan, Song Chen, Yun Chen, et al.
Oncotarget
|
September 17, 2016
Comparison of outcomes of tyrosine kinase inhibitor in first- or second-line therapy for advanced non-small-cell lung cancer patients with sensitive EGFR mutations
Jianlin Xu, Xueyan Zhang, Haitang Yang, et al.
Frontiers in Cell and Developmental Biology
|
April 1, 2022
Multi-Omics Signatures Identification for LUAD Prognosis Prediction Model Based on the Integrative Analysis of Immune and Hypoxia Signals
Yuqing Lou, Qin Shi, Yanwei Zhang, et al.
Cancer Cell International
|
January 7, 2021
PlGF knockdown attenuates hypoxia-induced stimulation of cell proliferation and glycolysis of lung adenocarcinoma through inhibiting Wnt/β-catenin pathway
Wei Zhang, Yanwei Zhang, Wensheng Zhou, et al.
Oncotargets and Therapy
|
November 2, 2016
The EGFR tyrosine kinase inhibitors as second-line therapy for EGFR wild-type non-small-cell lung cancer: a real-world study in People's Republic of China
Jianlin Xu, Guozheng Ding, Xueyan Zhang, et al.
Cancer Letters
|
February 17, 2022
The centromere-associated protein CENPU promotes cell proliferation, migration, and invasiveness in lung adenocarcinoma
Yuqing Lou, Jun Lu, Yanwei Zhang, et al.
Journal of Cellular and Molecular Medicine
|
February 20, 2020
Serum TNFRII: A promising biomarker for predicting the risk of subcentimetre lung adenocarcinoma
Minjuan Hu, Yanwei Zhang, Beibei Sun, et al.
Plos One
|
October 8, 2010
Alpha-adducin Gly460Trp polymorphism and hypertension risk: a meta-analysis of 22 studies including 14303 cases and 15961 controls
Kuo Liu, Jielin Liu, Yan Huang, et al.
Scientific Reports
|
December 2, 2016
Corrigendum: EGFR tyrosine kinase inhibitors versus chemotherapy as first-line therapy for non-small cell lung cancer patients with the L858R point mutation
Jianlin Xu, Haitang Yang, Bo Jin, et al.
Page
of 12